Tag: cell viability assays market growth analysis

Uncover key drivers, emerging technologies, and competitive movements shaping the cell viability assays market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Cell Viability Assays Market in 2030?

The cell viability assays market has experienced rapid expansion in recent years. It is projected to increase from $1.73 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. This market’s historical growth can be attributed to the broadening of in vitro research activities, rising pharmaceutical R&D expenditures, an increase in toxicology testing, the growing use of cell culture models, and the presence of standardized assay kits.

The cell viability assays market is expected to experience significant expansion in the upcoming years. Its size is projected to reach $2.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period can be attributed to several factors, including the increasing demand for high-throughput drug discovery, the rising adoption of automated assay platforms, the expansion of personalized medicine research, a growing focus on assay miniaturization, and the increasing integration of imaging-based viability analysis. Prominent trends anticipated in this period encompass the increasing adoption of high-sensitivity viability assays, the rising use of microplate-based detection systems, the growing demand for multiparametric cell health analysis, the expansion of drug screening applications, and an enhanced focus on reproducible assay protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Drivers Are Influencing Production Trends In The Cell Viability Assays Market?

The growing domain of cell-based therapeutics is anticipated to invigorate the expansion of the cell viability assay market in the coming years. Cell-based therapeutics refers to medical approaches that employ living cells to mend or substitute damaged tissue, address illnesses, or reinstate normal bodily functions. This progress in cell-based therapeutics is fueled by breakthroughs in biotechnology, escalating investments in regenerative medicine, the wider acceptance and application of cell therapies, and enhancements in cell engineering and manufacturing processes. Cell viability assays are instrumental in supporting cell-based therapeutics by confirming the vitality, operational capacity, and safety of the therapeutic cells, thus optimizing treatment outcomes and ensuring rigorous quality control. For instance, in 2023, according to information from the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the quantity of gene therapies in Phase III clinical trials rose by 10% in Q3 2023, marking the initial quarterly increase since Q3 2022. Therefore, the proliferation of cell-based therapeutics is a key driver for the growth of the cell viability assay market.

Which Segments Are Gaining Traction In The Cell Viability Assays Market?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Trends Are Projected To Support The Growth Of The Cell Viability Assays Market?

Leading entities within the cell viability assays market are actively engaged in creating advanced cell screening technologies aimed at enhancing precision and accelerating drug discovery processes. These cell screening innovations boost cell viability assays by facilitating high-volume, accurate, and swift examination of cellular well-being and reactions, consequently refining experimental setups and advancing the formulation of therapeutic approaches. An illustrative case occurred in May 2024, when Arralyze, a technology firm headquartered in Germany, unveiled CellShepherd, an advanced platform designed for single-cell analysis. This system employs exclusive nanowell glass arrays to condense cell-based assays, allowing for continuous, live monitoring. The self-contained unit provides accurate cell distribution, joint cultivation under sterile environments, and imaging capabilities using both brightfield and fluorescent channels. Its artificial intelligence-powered analysis ensures precise enumeration and monitoring of cells. This accessible platform meets the growing demand for exact single-cell investigations across biomedical and life science fields.

Who Are The Core Companies Influencing Trends In The Cell Viability Assays Market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Regions Are Projected To Dominate The Cell Viability Assays Market In The Coming Years?

North America was the largest region in the cell viability assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Viability Assays Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2026, By The Business Research Company

In Vitro Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Cell Viability Assays Market In The Coming Years?

In recent years, there’s been a notable expansion in the cell viability assays market. Projected growth sees the market value rising from $1.56 billion in 2024 to $1.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. This significant growth during the historic period can be ascribed to several factors such as enhanced investment in cancer-related research, an upsurge in pharmaceutical R&D spending, and expansion in the biotechnology sector. Other contributing factors include advancements in cell culture techniques, increasing demand for stem cell research, the growing necessity for toxicity testing, and an increase in the application of real time cell analysis systems. Additionally, an increase in the quantity of CROs (contract research organizations) has also played a vital role.

Expectations are high for robust growth in the cell viability assays market size over the next few years, with projected growth reaching $2.52 billion in 2029, reflecting a compound annual growth rate (CAGR) of 9.9%. The surge expected during the forecast period can be credited to the rising demand for customized medicine, an uptick in government funds for cell-based research, a growing emphasis on precision medicine and stem cell research applications, increased accessibility to automated cell viability analyzers, and a heightened occurrence of infectious diseases. Other contributing factors include enhanced focus on bettering assay precision and responsiveness, elevated awareness of the advantages of cell viability assays, increased development of organ-on-a-chip technologies, and burgeoning demand for regenerative medicine. The forecast period is also set to witness major trends including advancements in high throughput screening methods, the incorporation of AI and machine learning algorithms, the advent of real-time monitoring systems, the adoption of automated liquid handling systems, the formulation of multiplex assays for simultaneous cell viability measurement, adoption of greener and more sustainable reagents, the creation of user-friendly assay kits, advancements in electrochemical assays, the introduction of scalable cell viability assays, and the production of assays that are compatible with primary cells and stem cells.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Drivers Are Accelerating Expansion Of The Cell Viability Assays Market?

The growth of the cell viability assay market is anticipated to be driven by the surging cell-based therapeutics. These treatments involve the use of live cells to mend or substitute damaged tissue, treat diseases or reinstate standard functionality. This progress in cell-based therapeutics can be attributed to advancements in biotechnology, an upsurge in investment in regenerative medicine, escalating acceptance and implementation of cell therapies, along with development in cell engineering and manufacturing technologies. The functionality, safety, and health of therapeutic cells are assured by cell viability assays, hence enhancing treatment efficacy and quality control. As reported by the American Society of Gene & Cell Therapy, a not-for-profit medical and scientific organization based in the U.S., there were 38 trials in Q1 2023 for non-genetically modified cell therapies, an increase from the previous quarter, Q4 2022 by 7. Therefore, the cell viability assay market is propelled by the rise in cell-based therapeutics.

How Is The Global Cell Viability Assays Market Broken Down By Segment?

The cell viability assaysmarket covered in this report is segmented –

1) By Product: Consumables; Instruments

2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates

2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems

Which Market Trends Are Expected To Define The Future Of The Cell Viability Assays Market?

Leading enterprises within the cell viability assays market are focusing on creating advanced cell screening technologies to enhance precision and accelerate drug discovery processes. Such technologies significantly aid cell viability assays by allowing rapid, meticulous, and high-capacity analysis of cell health and reactions, thereby fine-tuning experimental conditions and bolstering the creation of therapy strategies. Take an example from May 2024 when Arralyze, a German tech firm, launched CellShepherd, a futuristic platform for single-cell examination. The platform relies on patented nanowell glass arrays to downsize cell-based assays for real-time tracking. This self-sufficient system renders accurate cell dispensing, co-culturing in sterile scenarios, and brightfield and fluorescent channel imaging. The AI-assisted analysis ensures precise cell counting and monitoring. Additionally, by being easy to use, this platform meets the growing demand for exact single-cell studies in the areas of biomedical and life science.

Which Firms Are Making The Biggest Impact In The Cell Viability Assays Market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Cell Viability Assays Market Size During 2025–2029?

The cell viability assays market has experienced substantial growth recently. It is forecast to grow from $1.56 billion in 2024 to $1.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.5%. The expansion observed in past periods can be attributed to increased investment in cancer research, rising pharmaceutical R&D expenditure, the burgeoning biotechnology sector, advanced cell culture techniques, a surge in demand for stem cell research, an escalated need for toxicity testing, broader utilization of real-time cell analysis systems, and an increase in contract research organizations (CROs).

The cell viability assays market is projected for significant expansion over the coming years, reaching “$2.52 billion in 2029, with a compound annual growth rate (CAGR) of 9.9%. This anticipated growth is driven by several factors, including the rising need for personalized and precision medicine, increased government investment in cell-based research, the expansion of stem cell research and its applications, a greater availability of automated cell viability analyzers, an uptick in infectious disease cases, a heightened emphasis on enhancing assay accuracy and sensitivity, broader understanding of the advantages of these assays, the emergence of organ-on-a-chip technologies, and the growing demand for regenerative medicine. Key trends during this period are expected to involve improvements in high-throughput screening techniques, the integration of AI and machine learning, the creation of real-time monitoring solutions, the widespread use of automated liquid handling systems, the creation of multiplex assays for concurrent cell viability measurement, the shift towards more sustainable and environmentally friendly reagents, the design of user-friendly assay kits, progress in electrochemical assays, the deployment of scalable cell viability assays, and the development of assays suitable for primary cells and stem cells.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Which Industry Drivers Are Expected To Accelerate The Cell Viability Assays Market From 2025 To 2029?

The projected expansion of cell-based therapeutics is anticipated to drive the advancement of the cell viability assay market in the future. These therapeutics involve medical interventions utilizing living cells to mend or substitute impaired tissue, combat illnesses, or re-establish typical bodily functions. The development of cell-based therapeutics is propelled by progress in biotechnology, rising investments in regenerative medicine, broader acceptance and implementation of cell therapies, and enhancements in cell engineering and production methods. Cell viability assays are crucial for cell-based therapeutics as they guarantee the vitality, operational capability, and secure nature of therapeutic cells, thus improving the effectiveness of treatments and maintaining quality control. An example provided by the American Society of Gene & Cell Therapy, a non-profit medical and scientific body based in the US, indicates that 38 trials for non-genetically modified cell therapies commenced in Q1 2023, representing an increase of 7 trials compared to the preceding quarter, Q4 2022. Consequently, the expansion of cell-based therapeutics is fueling the growth within the cell viability assay market.

What Are The Segment Types Shaping The Cell Viability Assays Market?

The cell viability assaysmarket covered in this report is segmented –

1) By Product: Consumables; Instruments

2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates

2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems

What Trends Are Redefining The Cell Viability Assays Market Dynamics?

Leading companies engaged in the cell viability assays market are developing innovative cell screening technologies to enhance accuracy and expedite drug discovery. Cell screening technologies boost cell viability assays by enabling high-throughput, precise, and rapid assessments of cell health and responses, thereby optimizing experimental conditions and advancing the creation of therapeutic strategies. For instance, in May 2024, Arralyze, a technology company based in Germany, launched CellShepherd, a cutting-edge platform designed for single-cell analysis. This system utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time observation. The autonomous setup provides accurate cell dispensing, sterile co-culturing, and imaging through brightfield and fluorescent channels. Its AI-driven analysis guarantees precise cell counting and tracking. This user-friendly platform addresses the growing requirement for accurate single-cell research in biomedical and life science applications.

Who Are The Core Companies Influencing The Cell Viability Assays Market Landscape?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Regional Growth Trends Are Shaping The Cell Viability Assays Market Outlook?

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Viability Assays Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Viability Assays Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

The rise in the market size of cell viability assays has been quick and substantial in the past few years. Estimated to grow from a size of $1.56 billion in 2024, it’s anticipated to reach up to $1.73 billion by 2025, marking a compound annual growth rate (CAGR) of 10.5%. Various factors have been responsible for the historic increase, which include escalated investments in cancer studies, amplified expenditure in the pharmaceutical R&D domain, growth in the biotechnology sector, advancements in cell culture procedures, growing demand for stem cell investigation, rising needs for toxicity evaluation, enhanced use of real-time cell analysis setups, and an increase in the presence of contract research organizations (CROs)._x000D_

_x000D_

The market for cell viability assays is anticipated to experience substantial growth in the near future, expanding to$2.52 billion in 2029 with a compound annual growth rate (CAGR) of 9.9%. The growth observed within the forecast period can be credited to factors such as the rising demand for personalized medication, increased government support for cell-based studies, a greater emphasis on precision medicine and the expansion of stem cell research and applications, along with a heightened availability of automated cell viability analyzers. Additionally, the rise in cases of infectious diseases, an increased emphasis on enhancing assay accuracy and sensitivity, more awareness regarding the advantages of cell viability assays, growth in organ on a chip technologies development, and an increased demand for regenerative medicine also contribute significantly. Future trends to look out for include advancements in high throughput screening, adoption of AI and machine learning, development of real-time monitoring systems, uptake of automated liquid handling systems, expanded multiplex assays for simultaneous cell viability measurement, the use of more sustainable and eco-friendly reagents, the advent of user-friendly assay kits, advancements in electrochemical assays, scalable cell viability assays implementation, and the creation of assays compatible with primary and stem cells._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Cell Viability Assays Market?#_x000D_

The cell viability assay market is set to expand due to the rising prominence of cell-based therapeutics. This refers to treatments that utilize living cells to mend or replace damaged tissue, treat diseases and revive regular function. The acceleration of cell-based therapeutics is propelled by advances in biotechnology, a rise in investment towards regenerative medicine, expanding adoption, and acceptance of cell therapies, along with enhancements in cell engineering and manufacturing technologies. Cell viability assays play a vital role in cell-based therapeutics by safeguarding the health, efficacy, and safety of therapeutic cells, consequently enhancing treatment effectiveness and quality control. The American Society of Gene & Cell Therapy, a nonprofit medical and scientific organization based in the U.S reported that 38 trials were launched for non-genetically modified cell therapies in the first quarter of 2023, which is seven more than the last quarter of 2022. Therefore, the burgeoning field of cell-based therapeutics is fueling the expansion of the cell viability assay market._x000D_

_x000D_

#Which Primary Segments of the Cell Viability Assays Market Are Driving Growth and Industry Transformations?#_x000D_

The cell viability assaysmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Consumables; Instruments_x000D_

2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications_x000D_

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates _x000D_

2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cell Viability Assays Market?# Market?#_x000D_

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Cell Viability Assays Industry Dynamics?#_x000D_

Leader organizations in the cell viability assays market are introducing groundbreaking cell screening technologies to boost precision and expedite drug discovery. These technologies enhance cell viability assays by ensuring high-precision, fast, and high-capacity analysis of cell health and responses, thereby refining experimental conditions and accelerating the establishment of therapeutic strategies. For example, in May 2024, Arralyze, a tech firm based in Germany, unveiled CellShepherd, an advanced platform designed for single-cell analysis. This platform uses proprietary nanowell glass arrays to downsize cell-based assays for realtime monitoring. The independent system provides accurate cell dispensing, co-culture in sterile environments, and imaging using brightfield and fluorescent channels. The AI-based evaluation ensures exact cell counting and tracking. This easy-to-use platform meets the escalating demand for meticulous single-cell study in biomedical and life science use cases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Cell Viability Assays Market?#_x000D_

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Viability Assays Market Growth Performance Trended Historically, And What Lies Ahead?

The scale of the cell viability assays market has expanded swiftly in recent times, increasing from $1.56 billion in 2024 to anticipated $1.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this surge during the historic period include heightened funding for cancer studies, escalating spendings on pharmaceutical research & development, enlargement of the biotechnology sector, acceleration in progress in cell culture techniques, surge in stem cell research demand, growing necessity for toxicity testing, elevated use of real-time cell analysis systems, and an increase in the amount of contract research organizations (CROs).

What Is the Forecast for the Cell Viability Assays Market Size Through 2029?

The foreseeable advancement in the market size of cell viability assays is impressive, with anticipated growth hitting $2.58 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.5%. This expected increase within the forecasted period is due to the increased need for personalized healthcare, enhanced government support for cell-based studies, a more significant focus on precision medicine and stem cell research, and more accessible automated cell viability analyzers. A surge in the spread of infectious diseases, efforts towards boosting the precision and sensitivity of assays, better understanding of cell viability assays benefits, increasing development of organ-on-a-chip technologies, as well as heightened demand for regenerative medicine are other contributing factors. The forecast period also indicates trends such as improvements in high throughput screening, incorporation of artificial intelligence and machine learning, real-time monitoring systems development, application of automated fluid management systems, progression in the creation of multiplex assays for simultaneous cell viability measurement, usage of sustainable, environmentally friendly reagents, user-friendly assay kits development, advancements in electrochemical assays, scalable cell viability assays integration, as well as the development of assays that are compatible with primary and stem cells.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What are the Key Market Players in Cell Viability Assays Market and How They’re Evolving?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

What Are the Primary Growth Drivers in the Cell Viability Assays Market?

The surge in cell-based therapeutics is anticipated to boost the expansion of the cell viability assay market. Cell-based therapeutics involve treatments deploying living cells to mend or substitute damaged tissues, address diseases, or reestablish usual functioning. The escalation in cell-based therapeutics owes to breakthroughs in biotechnology, rising investment in regenerative medicine, a broadening acceptance and implementation of cell therapies, coupled with enhancement in cell engineering and manufacturing technologies. This therapeutics gains from cell viability assays by maintaining the well-being, functionality, and security of therapeutic cells, consequently amplifying treatment efficacy and quality control. For example, according to the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization located in the US, they commenced 38 trials for non-genetically modified cell therapies in Q1 2023, an increase of 7 from the prior quarter, Q4 2022. Thus, the growing trend of cell-based therapeutics is influencing the growth of the cell viability assay market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

What Are the Leading Segments in the Global Cell Viability Assays Industry?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Are the Key Market Trends in the Cell Viability Assays Industry?

Leading organizations in the cell viability assays marketplace are engineering advanced cell screening procedures to enhance precision and expedite the drug discovery process. These cell screening techniques amplify the effectiveness of cell viability assays through their ability to perform a quick, detailed, and high-volume investigation of cell health and reactions. This optimizes experimental circumstances and advances the formulation of therapeutic methodologies. For example, in May 2024, Arralyze, a tech firm based in Germany, launched CellShepherd, a ground-breaking platform for single-cell examination. It leverages unique nanowell glass arrays for shrinking cell-based assays, facilitating real-time observation. The self-sufficient system provides exact cell dispensing, co-culturing under sterile conditions, and imaging using brightfield and fluorescent channels. The AI-fueled analysis ensures precise cell counting and tracing, making it a user-friendly platform that meets the growing demand for accurate single-cell studies in the biomedical and life science sectors.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Is the Regional Outlook for the Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

This Report Delivers Insight On:

1. How big is the cell viability assays market, and how is it changing globally?

2. Who are the major companies in the cell viability assays market, and how are they performing?

3. What are the key opportunities and risks in the cell viability assays market right now?

4. Which products or customer segments are growing the most in the cell viability assays market?

5. What factors are helping or slowing down the growth of the cell viability assays market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cell viability assays industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Cell Viability Assays Market Size from 2025 to 2034?

The market for cell viability tests has seen a steep increase in its size of late. Its growth is projected to continue from $1.56 billion in 2024 to reach $1.73 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.8%. The escalation in the erstwhile period can be connected to increased funding for cancer studies, a climb in pharmaceutical research & development spending, an expansion in the biotech sector, enhanced progress in cell culture methodologies, an uprising demand for stem cell research, a higher necessity for toxicity screening, a rise in the application of real-time cell analysis systems, and an escalating count of CROs (contract research organizations).

Anticipations are high for the cell viability assays market as it is predicted to experience swift expansion in the coming years, with its value anticipated to reach $2.58 billion by 2029, showing a compound annual growth rate (CAGR) of 10.5%. Numerous factors will contribute to this growth during the forecast period, including increased demand for personal medicine, higher government investment in cell-based studies, intensified focus on precision medicine, and growth in stem cell research and its applications. Other attributors include the rising availability of automated cell viability analyzers, increased cases of infectious diseases, emphasis on enhancing assay precision and sensitivity, expanded awareness about the advantages of cell viability assays, development in organ-on-chip technology, and a surge in demand for regenerative medicines. The forecast period trends are expected to be determined by advancements in high throughput screening techniques, the integration of AI and machine learning protocols, the invention of real-time tracking systems, utilization of automated liquid management systems, creation of multiplex assays for concurrent cell viability measurements, encouraging the use of sustainable and environmentally-friendly reagents, the design of user-friendly assay kits, progressions in electrochemical assays, the execution of scalable cell viability assays, and the designing of assays harmonious with primary cells and stem cells.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Cell Viability Assays Market?

The surge in cell-based therapeutics is set to promote the expansion of the cell viability assay market. Cell-based therapies, which utilize living cells to mend or replace injured tissue, treat ailments, or regain normal function, are enhancing the growth. This progress is powered by developments in the field of biotechnology, amplified funding in regenerative medicine, rising acceptance and deployment of cell therapies, and enhancements in cell engineering and production technologies. Cell viability assays bolster cell-based therapeutics by assuring the well-being, functionality, and safety of therapeutic cells, thus maximizing treatment effectiveness and quality supervision. For example, the American Society of Gene & Cell Therapy, a not-for-profit medical and scientific organization located in the US, launched 38 trials for non-genetically altered cell therapies in Q1 2023, an increase of seven from the preceding quarter, Q4 2022. Consequently, the boost in cell-based therapeutics is stimulating the growth of the cell viability assay market.

Which Segments in the Cell Viability Assays Offer the Most Growth?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

What Are the Fastest-Growing Geographies in the Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering the Cell Viability Assays Market Direction?

In the cell viability assays market, significant businesses are innovating cell screening technologies to enhance precision and hasten drug discovery. Cell screening methodologies augment cell viability assays by facilitating high-throughput, accurate, and quick examination of cell health and reactions, thereby refining experimental conditions and upgrading the creation of therapeutic strategies. For example, in May 2024, Arralyze, a tech firm based in Germany, rolled out CellShepherd, a state-of-the-art platform for single-cell analysis. The platform uses its own nanowell glass arrays to miniaturize cell-based assays for continuous monitoring. The standalone system allows for precise cell dispensing, co-culturing in sterile environments, and imaging with brightfield and fluorescent channels. Thanks to AI-driven evaluation, it ensures precise cell counting and tracking. This user-friendly platform meets the growing demand for accurate single-cell study in biomedical and life-science applications.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Are the Key Elements That Define the Cell Viability Assays Market?

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model